In silico ADME/tox comes of age: twenty years later

References

• Brown TB, Mann B, Ryder N, Subbiah M, Kaplan J, Dhariwal P, Neelakantan A, Shyam P, Sastry G, Askell A, and, others. 2020. Language models are few-shot learners. Available at: https://arxiv.org/abs/2005.14165.
   Google Scholar
• Bubeck S, Chandrasekaran V, Eldan R, Gehrke J, Horvitz E, Kamar E, Lee P, Lee YT, Li Y, Lundberg SM, and, others. 2023. Sparks of artificial general intelligence: early experiments with GPT-4. https://arxiv.org/abs/2303.12712.
   Google Scholar
• Butina D, Segall MD, Frankcombe K. 2002. Predicting ADME properties in silico: methods and models. Drug Discov Today. 7(11):S83–S8. doi:10.1016/s1359-6446(02)02288-2.
   PubMed Web of Science ®Google Scholar
• Chowdhery A, Narang S, Devlin J, Bosma M, Mishra G, Roberts A, Barham P, Chung HW, Sutton C, Gehrmann S, and, others. 2022. PaLM: scaling language modeling with pathways. p arXiv:2204.02311.
   Google Scholar
• Cronin MTD, Belfield SJ, Briggs KA, Enoch SJ, Firman JW, Frericks M, Garrard C, Maccallum PH, Madden JC, Pastor M, and, others. 2023. Making in silico predictive models for toxicology FAIR. Regul Toxicol Pharmacol. 140:105385. doi:10.1016/j.yrtph.2023.105385.
   PubMed Web of Science ®Google Scholar
• Di Lascio E, Gerebtzoff G, Rodriguez-Perez R. 2023. Systematic evaluation of local and global machine learning models for the prediction of ADME properties. Mol Pharm. 20(3):1758–1767. doi:10.1021/acs.molpharmaceut.2c00962.
   PubMed Web of Science ®Google Scholar
• Dickins M, Modi S. 2002. The importance of predictive ADME simulation. Drug Discov Today. 7(14):755–756. doi:10.1016/s1359-6446(02)02357-7.
   PubMed Web of Science ®Google Scholar
• Ekins S. 2014. Progress in computational toxicology. J Pharmacol Toxicol Methods. 69(2):115–140. doi:10.1016/j.vascn.2013.12.003.
   PubMed Web of Science ®Google Scholar
• Ekins S, Boulanger B, Swaan PW, Hupcey MA. 2002. Towards a new age of virtual ADME/TOX and multidimensional drug discovery. J Comput Aided Mol Des. 16(5-6):381–401. doi:10.1023/a:1020816005910.
   PubMed Web of Science ®Google Scholar
• Ekins S, de Groot MJ, Jones JP. 2001. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites. Drug Metab Dispos. 29(7):936–944.
   PubMed Web of Science ®Google Scholar
• Ekins S, Nikolsky Y, Nikolskaya T. 2005. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Trends Pharmacol Sci. 26(4):202–209. doi:10.1016/j.tips.2005.02.006.
   PubMed Web of Science ®Google Scholar
• Ekins S, Ring BJ, Grace J, McRobie-Belle DJ, Wrighton SA. 2000a. Present and future in vitro approaches for drug metabolism. J Pharmacol Toxicol Methods. 44(1):313–324. doi:10.1016/s1056-8719(00)00110-6.
   PubMed Web of Science ®Google Scholar
• Ekins S, Waller CL, Swaan PW, Cruciani G, Wrighton SA, Wikel JH. 2000b. Progress in predicting human ADME parameters in silico. J Pharmacol Toxicol Methods. 44(1):251–272. doi:10.1016/s1056-8719(00)00109-x.
   PubMed Web of Science ®Google Scholar
• Ekins S, Williams AJ. 2010. Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development. Lab Chip. 10(1):13–22. doi:10.1039/b917760b.
   PubMed Web of Science ®Google Scholar
• Ekins S, Wrighton SA. 2001. Application of in silico approaches to predicting drug–drug interactions. J Pharmacol Toxicol Methods. 45(1):65–69. doi:10.1016/s1056-8719(01)00119-8.
   PubMed Web of Science ®Google Scholar
• Esposito C, Wang S, Lange UEW, Oellien F, Riniker S. 2020. Combining machine learning and molecular dynamics to predict P-glycoprotein substrates. J Chem Inf Model. 60(10):4730–4749. doi:10.1021/acs.jcim.0c00525.
   PubMed Web of Science ®Google Scholar
• Gill J, Moullet M, Martinsson A, Miljkovic F, Williamson B, Arends RH, Pilla Reddy V. 2023. Evaluating the performance of machine-learning regression models for pharmacokinetic drug-drug interactions. CPT Pharmacometr Syst Pharmacol. 12(1):122–134. doi:10.1002/psp4.12884.
   PubMedGoogle Scholar
• Goller AH, Kuhnke L, Montanari F, Bonin A, Schneckener S, Ter Laak A, Wichard J, Lobell M, Hillisch A. 2020. Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades. Drug Discov Today. 25(9):1702–1709. doi:10.1016/j.drudis.2020.07.001.
   PubMed Web of Science ®Google Scholar
• Gupta RR, Gifford EM, Liston T, Waller CL, Hohman M, Bunin BA, Ekins S. 2010. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties. Drug Metab Dispos. 38(11):2083–2090. doi:10.1124/dmd.110.034918.
   PubMed Web of Science ®Google Scholar
• Hamzic S, Lewis R, Desrayaud S, Soylu C, Fortunato M, Gerebtzoff G, Rodriguez-Perez R. 2022. Predicting in vivo compound brain penetration using multi-task graph neural networks. J Chem Inf Model. 62(13):3180–3190. doi:10.1021/acs.jcim.2c00412.
   PubMed Web of Science ®Google Scholar
• He J, Nittinger E, Tyrchan C, Czechtizky W, Patronov A, Bjerrum EJ, Engkvist O. 2022. Transformer-based molecular optimization beyond matched molecular pairs. J Cheminform. 14(1):18. doi:10.1186/s13321-022-00599-3.
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Borgeaud S, Mensch A, Buchatskaya E, Cai T, Rutherford E, de Las Casas D, Hendricks LA, Welbl J, Clark A, and, others. 2022. Training compute-optimal large language models. p arXiv:2203.15556.
   Google Scholar
• Ietswaart R, Arat S, Chen AX, Farahmand S, Kim B, DuMouchel W, Armstrong D, Fekete A, Sutherland JJ, Urban L. 2020. Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology. EBioMedicine. 57:102837. doi:10.1016/j.ebiom.2020.102837.
   PubMed Web of Science ®Google Scholar
• Irwin R, Dimitriadis S, He J, Bjerrum EJ. 2022. Chemformer: a pre-trained transformer for computational chemistry. Mach Learn: sci Technol. 3(1):015022.
   Google Scholar
• Isert C, Kromann JC, Stiefl N, Schneider G, Lewis RA. 2023. Machine learning for fast, quantum mechanics-based approximation of drug lipophilicity. ACS Omega. 8(2):2046–2056. doi:10.1021/acsomega.2c05607.
   PubMed Web of Science ®Google Scholar
• Janssen APA, Grimm SH, Wijdeven RHM, Lenselink EB, Neefjes J, van Boeckel CAA, van Westen GJP, van der Stelt M. 2019. Drug discovery maps, a machine learning model that visualizes and predicts kinome-inhibitor interaction landscapes. J Chem Inf Model. 59(3):1221–1229. doi:10.1021/acs.jcim.8b00640.
   PubMed Web of Science ®Google Scholar
• Kennedy T. 1997. Managing the drug discovery/development interface. Drug Discovery Today. 2(10):436–444. doi:10.1016/S1359-6446(97)01099-4.
   Web of Science ®Google Scholar
• Komura H, Watanabe R, Kawashima H, Ohashi R, Kuroda M, Sato T, Honma T, Mizuguchi K. 2021. A public-private partnership to enrich the development of in silico predictive models for pharmacokinetic and cardiotoxic properties. Drug Discov Today. 26(5):1275–1283. doi:10.1016/j.drudis.2021.01.024.
   PubMed Web of Science ®Google Scholar
• Konečný J, McMahan B, Ramage D. 2015. Federated optimization: distributed optimization beyond the datacenter. p arXiv:1511.03575.
   Google Scholar
• Landrum G, RDkit 2020. Available at: https://www.rdkit.org.
   Google Scholar
• Lane TR, Harris J, Urbina F, Ekins S. 2023. Comparing LD50/LC50 machine learning models for multiple species. J Chem Health Saf. 30(2):83–97. doi:10.1021/acs.chas.2c00088.
   PubMed Web of Science ®Google Scholar
• Lewis M, Liu Y, Goyal N, Gazvininejad M, Levy O, Stoyanov V, Zettlemoyer L. 2019. BART: denoising sequence-to-sequence pre-training for natural language generation, translation, and comprehension. https://arxiv.org/abs/1910.13461.
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 23(1-3):3–25. doi:10.1016/S0169-409X(96)00423-1.
   Web of Science ®Google Scholar
• Liu X, Ye K, van Vlijmen HWT, Emmerich MTM, Ij AP, van Westen GJP. 2021. DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology. J Cheminform. 13(1):85. doi:10.1186/s13321-021-00561-9.
   PubMed Web of Science ®Google Scholar
• Lombardo F, Desai PV, Arimoto R, Desino KE, Fischer H, Keefer CE, Petersson C, Winiwarter S, Broccatelli F. 2017. In silico absorption, distribution, metabolism, excretion, and pharmacokinetics (ADME-PK): Utility and best practices. An industry perspective from the international consortium for innovation through quality in pharmaceutical development. J Med Chem. 60(22):9097–9113. doi:10.1021/acs.jmedchem.7b00487.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang Y. 2022. Unified deep learning model for multitask reaction predictions with explanation. J Chem Inf Model. 62(6):1376–1387. doi:10.1021/acs.jcim.1c01467.
   PubMed Web of Science ®Google Scholar
• Mansouri K, Karmaus AL, Fitzpatrick J, Patlewicz G, Pradeep P, Alberga D, Alepee N, Allen TEH, Allen D, Alves VM, et al. 2021. Erratum: CATMoS: Collaborative acute toxicity modeling suite. Environ Health Perspect. 129(10):109001. doi:10.1289/EHP10369.
   PubMed Web of Science ®Google Scholar
• Martin MT, Koza-Taylor P, Di L, Watt ED, Keefer C, Smaltz D, Cook J, Jackson JP. 2022. Early drug-induced liver injury risk screening: "Free," as good as it gets. Toxicol Sci. 188(2):208–218. doi:10.1093/toxsci/kfac054.
   PubMed Web of Science ®Google Scholar
• Minerali E, Foil DH, Zorn KM, Ekins S. 2020. Evaluation of assay central® machine learning models for rat acute oral toxicity prediction. ACS Sustainable Chem Eng. 8(42):16020–16027. doi:10.1021/acssuschemeng.0c06348.
   Web of Science ®Google Scholar
• Mittone G, Svoboda F, Aldinucci M, Lane ND, Lio P. 2023. A federated learning benchmark for drug-target interaction. p arXiv:2302.07684. doi:10.1145/3543873.3587687.
   Google Scholar
• Murad N, Pasikanti KK, Madej BD, Minnich A, McComas JM, Crouch S, Polli JW, Weber AD. 2021. Predicting volume of distribution in humans: performance of in silico methods for a large set of structurally diverse clinical compounds. Drug Metab Dispos. 49(2):169–178. doi:10.1124/dmd.120.000202.
   PubMed Web of Science ®Google Scholar
• Muster W, Breidenbach A, Fischer H, Kirchner S, Muller L, Pahler A. 2008. Computational toxicology in drug development. Drug Discov Today. 13(7-8):303–310. doi:10.1016/j.drudis.2007.12.007.
   PubMed Web of Science ®Google Scholar
• Obrezanova O, Martinsson A, Whitehead T, Mahmoud S, Bender A, Miljkovic F, Grabowski P, Irwin B, Oprisiu I, Conduit G, and, others. 2022. Prediction of in vivo pharmacokinetic parameters and time-exposure curves in rats using machine learning from the chemical structure. Mol Pharm. 19(5):1488–1504. doi:10.1021/acs.molpharmaceut.2c00027.
   PubMed Web of Science ®Google Scholar
• Oldenhof M, Ács G, Pejó B, Schuffenhauer A, Holway N, Sturm N, Dieckmann A, Fortmeier O, Boniface E, Mayer C, and, others. 2022. Industry-scale orchestrated federated learning for drug discovery. p arXiv:2210.08871.
   Google Scholar
• Pillai N, Dasgupta A, Sudsakorn S, Fretland J, Mavroudis PD. 2022. Machine learning guided early drug discovery of small molecules. Drug Discov Today. 27(8):2209–2215. doi:10.1016/j.drudis.2022.03.017.
   PubMed Web of Science ®Google Scholar
• Poongavanam V, Kolling F, Giese A, Goller AH, Lehmann L, Meibom D, Kihlberg J. 2023. Predictive modeling of PROTAC cell permeability with machine learning. ACS Omega. 8(6):5901–5916. doi:10.1021/acsomega.2c07717.
   PubMed Web of Science ®Google Scholar
• Ramesh A, Dhariwal P, Nichol A, Chu C, Chen M. 2022. Hierarchical text-conditional image generation with CLIP latents. Available at: https://arxiv.org/abs/2204.06125.
   Google Scholar
• Rao M, Nassiri V, Alhambra C, Snoeys J, Van Goethem F, Irrechukwu O, Aleo MD, Geys H, Mitra K, Will Y. 2023. AI/ML models to predict the severity of drug-induced liver injury for small molecules. Chem Res Toxicol. 36(7):1129–1139. doi:10.1021/acs.chemrestox.3c00098.
   PubMed Web of Science ®Google Scholar
• Rao MS, Gupta R, Liguori MJ, Hu M, Huang X, Mantena SR, Mittelstadt SW, Blomme EAG, Van Vleet TR. 2019. Novel computational approach to predict off-target interactions for small molecules. Front Big Data. 2:25. doi:10.3389/fdata.2019.00025.
   PubMedGoogle Scholar
• Schaduangrat N, Lampa S, Simeon S, Gleeson MP, Spjuth O, Nantasenamat C. 2020. Towards reproducible computational drug discovery. J Cheminform. 12(1):9. doi:10.1186/s13321-020-0408-x.
   PubMed Web of Science ®Google Scholar
• Schmidt F, Wenzel J, Halland N, Gussregen S, Delafoy L, Czich A. 2019. Computational investigation of drug phototoxicity: photosafety assessment, photo-toxophore identification, and machine learning. Chem Res Toxicol. 32(11):2338–2352. doi:10.1021/acs.chemrestox.9b00338.
   PubMed Web of Science ®Google Scholar
• Selick HE, Beresford AP, Tarbit MH. 2002. The emerging importance of predictive ADME simulation in drug discovery. Drug Discov Today. 7(2):109–116. doi:10.1016/s1359-6446(01)02100-6.
   PubMed Web of Science ®Google Scholar
• Siramshetty V, Williams J, Nguyễn Ð-T, Neyra J, Southall N, Mathé E, Xu X, Shah P. 2021. Validating ADME QSAR models using marketed drugs. SLAS Discov. 26(10):1326–1336. doi:10.1177/24725552211017520.
   PubMed Web of Science ®Google Scholar
• Srivastava A, Rastogi A, Rao A, Shoeb AAM, Abid A, Fisch A, Brown AR, Santoro A, Gupta A, Garriga-Alonso A, and, others. 2022. Beyond the imitation game: quantifying and extrapolating the capabilities of language models. p arXiv:2206.04615.
   Google Scholar
• Stahl M, Guba W, Kansy M. 2006. Integrating molecular design resources within modern drug discovery research: the Roche experience. Drug Discov Today. 11(7-8):326–333. doi:10.1016/j.drudis.2006.02.008.
   PubMed Web of Science ®Google Scholar
• Stoyanova R, Katzberger PM, Komissarov L, Khadhraoui A, Sach-Peltason L, Groebke Zbinden K, Schindler T, Manevski N. 2023. Computational predictions of nonclinical pharmacokinetics at the drug design stage. J Chem Inf Model. 63(2):442–458. doi:10.1021/acs.jcim.2c01134.
   PubMed Web of Science ®Google Scholar
• Tysinger EP, Rai BK, Sinitskiy AV. 2023. Can we quickly learn to "translate" bioactive molecules with transformer models? J Chem Inf Model. 63(6):1734–1744. doi:10.1021/acs.jcim.2c01618.
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd H, Gifford E. 2003. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov. 2(3):192–204. doi:10.1038/nrd1032.
   PubMed Web of Science ®Google Scholar
• Van Rompaey D, Morrison D, Van Den Bergh A, Wegner JK. 2023. A symbolic regression model for the prediction of drug binding to human liver microsomes. Mol Pharm. 20(5):2436–2442. doi:10.1021/acs.molpharmaceut.2c01048.
   PubMed Web of Science ®Google Scholar
• Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, HGomez AN, Kaiser L, Plusukhin I. 2017. Attention is all you need. ArXiv, 1706.03762.
   Google Scholar
• Volak LP, Duevel HM, Humphreys S, Nettleton D, Phipps C, Pike A, Rynn C, Scott-Stevens P, Zhang D, Zientek M. 2023. Industry perspective on the pharmacokinetic and ADME characterization of heterobifunctional protein degraders. Drug Metab Dispos. 51(7):792–803. doi:10.1124/dmd.122.001154.
   PubMed Web of Science ®Google Scholar
• Weininger D. 1988. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci. 28(1):31–36. doi:10.1021/ci00057a005.
   Google Scholar
• Willighagen EL, Mayfield JW, Alvarsson J, Berg A, Carlsson L, Jeliazkova N, Kuhn S, Pluskal T, Rojas-Cherto M, Spjuth O, and, others. 2017. The Chemistry Development Kit (CDK) v2.0: atom typing, depiction, molecular formulas, and substructure searching. J Cheminform. 9(1):33. doi:10.1186/s13321-017-0220-4.
   PubMed Web of Science ®Google Scholar
• Winiwarter S, Chang G, Desai P, Menzel K, Faller B, Arimoto R, Keefer C, Broccatelli F. 2019. Correction to "prediction of fraction unbound in microsomal and hepatocyte incubations: a comparison of methods across industry datasets". Mol Pharm. 16(11):4755. doi:10.1021/acs.molpharmaceut.9b00993.
   PubMed Web of Science ®Google Scholar
• Yu H, Adedoyin A. 2003. ADME-Tox in drug discovery: integration of experimental and computational technologies. Drug Discov Today. 8(18):852–861. doi:10.1016/s1359-6446(03)02828-9.
   PubMed Web of Science ®Google Scholar
• Zeller A, Brigo A, Brink A, Guerard M, Lang D, Muster W, Runge F, Sutter A, Vock E, Wichard J, et al. 2020. Genotoxicity assessment of drug metabolites in the context of MIST and beyond. Chem Res Toxicol. 33(1):10–19. doi:10.1021/acs.chemrestox.9b00348.
   PubMed Web of Science ®Google Scholar
• Zhang J, Norinder U, Svensson F. 2021. Deep learning-based conformal prediction of toxicity. J Chem Inf Model. 61(6):2648–2657. doi:10.1021/acs.jcim.1c00208.
   PubMed Web of Science ®Google Scholar